197 related articles for article (PubMed ID: 25247294)
1. The chromatin remodeling factor CHD5 is a transcriptional repressor of WEE1.
Quan J; Adelmant G; Marto JA; Look AT; Yusufzai T
PLoS One; 2014; 9(9):e108066. PubMed ID: 25247294
[TBL] [Abstract][Full Text] [Related]
2. The tumour suppressor CHD5 forms a NuRD-type chromatin remodelling complex.
Kolla V; Naraparaju K; Zhuang T; Higashi M; Kolla S; Blobel GA; Brodeur GM
Biochem J; 2015 Jun; 468(2):345-52. PubMed ID: 25825869
[TBL] [Abstract][Full Text] [Related]
3. The tumor suppressor chromodomain helicase DNA-binding protein 5 (CHD5) remodels nucleosomes by unwrapping.
Quan J; Yusufzai T
J Biol Chem; 2014 Jul; 289(30):20717-26. PubMed ID: 24923445
[TBL] [Abstract][Full Text] [Related]
4. Role of CHD5 in human cancers: 10 years later.
Kolla V; Zhuang T; Higashi M; Naraparaju K; Brodeur GM
Cancer Res; 2014 Feb; 74(3):652-8. PubMed ID: 24419087
[TBL] [Abstract][Full Text] [Related]
5. Expression of the neuron-specific protein CHD5 is an independent marker of outcome in neuroblastoma.
Garcia I; Mayol G; Rodríguez E; Suñol M; Gershon TR; Ríos J; Cheung NK; Kieran MW; George RE; Perez-Atayde AR; Casala C; Galván P; de Torres C; Mora J; Lavarino C
Mol Cancer; 2010 Oct; 9():277. PubMed ID: 20950435
[TBL] [Abstract][Full Text] [Related]
6. CHD5, a brain-specific paralog of Mi2 chromatin remodeling enzymes, regulates expression of neuronal genes.
Potts RC; Zhang P; Wurster AL; Precht P; Mughal MR; Wood WH; Zhang Y; Becker KG; Mattson MP; Pazin MJ
PLoS One; 2011; 6(9):e24515. PubMed ID: 21931736
[TBL] [Abstract][Full Text] [Related]
7. CHD5, a new member of the chromodomain gene family, is preferentially expressed in the nervous system.
Thompson PM; Gotoh T; Kok M; White PS; Brodeur GM
Oncogene; 2003 Feb; 22(7):1002-11. PubMed ID: 12592387
[TBL] [Abstract][Full Text] [Related]
8. Chromodomain helicase DNA binding protein 5 plays a tumor suppressor role in human breast cancer.
Wu X; Zhu Z; Li W; Fu X; Su D; Fu L; Zhang Z; Luo A; Sun X; Fu L; Dong JT
Breast Cancer Res; 2012 May; 14(3):R73. PubMed ID: 22569290
[TBL] [Abstract][Full Text] [Related]
9. CHD4 Is a Peripheral Component of the Nucleosome Remodeling and Deacetylase Complex.
Low JK; Webb SR; Silva AP; Saathoff H; Ryan DP; Torrado M; Brofelth M; Parker BL; Shepherd NE; Mackay JP
J Biol Chem; 2016 Jul; 291(30):15853-66. PubMed ID: 27235397
[TBL] [Abstract][Full Text] [Related]
10. CHD5, a tumor suppressor gene deleted from 1p36.31 in neuroblastomas.
Fujita T; Igarashi J; Okawa ER; Gotoh T; Manne J; Kolla V; Kim J; Zhao H; Pawel BR; London WB; Maris JM; White PS; Brodeur GM
J Natl Cancer Inst; 2008 Jul; 100(13):940-9. PubMed ID: 18577749
[TBL] [Abstract][Full Text] [Related]
11. CHD3 and CHD4 form distinct NuRD complexes with different yet overlapping functionality.
Hoffmeister H; Fuchs A; Erdel F; Pinz S; Gröbner-Ferreira R; Bruckmann A; Deutzmann R; Schwartz U; Maldonado R; Huber C; Dendorfer AS; Rippe K; Längst G
Nucleic Acids Res; 2017 Oct; 45(18):10534-10554. PubMed ID: 28977666
[TBL] [Abstract][Full Text] [Related]
12. Retinoic acid-induced CHD5 upregulation and neuronal differentiation of neuroblastoma.
Higashi M; Kolla V; Iyer R; Naraparaju K; Zhuang T; Kolla S; Brodeur GM
Mol Cancer; 2015 Aug; 14():150. PubMed ID: 26245651
[TBL] [Abstract][Full Text] [Related]
13. Mechanisms of CHD5 Inactivation in neuroblastomas.
Koyama H; Zhuang T; Light JE; Kolla V; Higashi M; McGrady PW; London WB; Brodeur GM
Clin Cancer Res; 2012 Mar; 18(6):1588-97. PubMed ID: 22294723
[TBL] [Abstract][Full Text] [Related]
14. NAB2 represses transcription by interacting with the CHD4 subunit of the nucleosome remodeling and deacetylase (NuRD) complex.
Srinivasan R; Mager GM; Ward RM; Mayer J; Svaren J
J Biol Chem; 2006 Jun; 281(22):15129-37. PubMed ID: 16574654
[TBL] [Abstract][Full Text] [Related]
15. Regulation of DNA-damage responses and cell-cycle progression by the chromatin remodelling factor CHD4.
Polo SE; Kaidi A; Baskcomb L; Galanty Y; Jackson SP
EMBO J; 2010 Sep; 29(18):3130-9. PubMed ID: 20693977
[TBL] [Abstract][Full Text] [Related]
16. The epigenetic modifier CHD5 functions as a novel tumor suppressor for renal cell carcinoma and is predominantly inactivated by promoter CpG methylation.
Du Z; Li L; Huang X; Jin J; Huang S; Zhang Q; Tao Q
Oncotarget; 2016 Apr; 7(16):21618-30. PubMed ID: 26943038
[TBL] [Abstract][Full Text] [Related]
17. Physical and functional interactions between the histone H3K4 demethylase KDM5A and the nucleosome remodeling and deacetylase (NuRD) complex.
Nishibuchi G; Shibata Y; Hayakawa T; Hayakawa N; Ohtani Y; Sinmyozu K; Tagami H; Nakayama J
J Biol Chem; 2014 Oct; 289(42):28956-70. PubMed ID: 25190814
[TBL] [Abstract][Full Text] [Related]
18.
Werren EA; Guxholli A; Jones N; Wagner M; Hannibal I; Granadillo JL; Tyndall AV; Moccia A; Kuehl R; Levandoski KM; Day-Salvatore DL; Wheeler M; ; Chong JX; Bamshad MJ; Innes AM; Pierson TM; Mackay JP; Bielas SL; Martin DM
HGG Adv; 2023 Jul; 4(3):100198. PubMed ID: 37181331
[TBL] [Abstract][Full Text] [Related]
19. FOG-1 recruits the NuRD repressor complex to mediate transcriptional repression by GATA-1.
Hong W; Nakazawa M; Chen YY; Kori R; Vakoc CR; Rakowski C; Blobel GA
EMBO J; 2005 Jul; 24(13):2367-78. PubMed ID: 15920470
[TBL] [Abstract][Full Text] [Related]
20. Role of microRNAs in epigenetic silencing of the CHD5 tumor suppressor gene in neuroblastomas.
Naraparaju K; Kolla V; Zhuang T; Higashi M; Iyer R; Kolla S; Okawa ER; Blobel GA; Brodeur GM
Oncotarget; 2016 Mar; 7(13):15977-85. PubMed ID: 26895110
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
